NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA

Ernst R. Berndt, Adrian H. B. Gottschalk, Matthew W. Strobeck

Chapter in NBER book Innovation Policy and the Economy, Volume 6 (2006), Adam B. Jaffe, Josh Lerner and Scott Stern, editors (p. 91 - 122)
Conference held April 19, 2005
Published in August 2006 by The MIT Press
in NBER Book Series Innovation Policy and the Economy

download in pdf format
   (358 K)

email paper

This paper is available as PDF (358 K) or via email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

This chapter first appeared as NBER working paper w11425, Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA, Ernst R. Berndt, Adrian H. B. Gottschalk, Matthew W. Strobeck
Users who downloaded this chapter also downloaded these:
Gilbert Looking for Mr. Schumpeter: Where Are We in the Competition-Innovation Debate?
Berndt, Gottschalk, and Strobeck w11425 Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA
Anton, Greene, and Yao Policy Implications of Weak Patent Rights
Cockburn Is the Pharmaceutical Industry in a Productivity Crisis?
Jaffe and Lerner Innovation and its Discontents
 
Publications
Activities
Meetings
NBER Videos
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us